1. Home
  2. MPLT vs HLMN Comparison

MPLT vs HLMN Comparison

Compare MPLT & HLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

HOLD

Current Price

$13.34

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Hillman Solutions Corp.

HLMN

Hillman Solutions Corp.

HOLD

Current Price

$7.71

Market Cap

1.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPLT
HLMN
Founded
2018
1964
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
MPLT
HLMN
Price
$13.34
$7.71
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
5
Target Price
$32.67
$11.60
AVG Volume (30 Days)
572.6K
1.2M
Earning Date
05-28-2026
04-27-2026
Dividend Yield
N/A
N/A
EPS Growth
82.39
122.22
EPS
N/A
0.08
Revenue
N/A
$1,552,224,000.00
Revenue This Year
N/A
$7.65
Revenue Next Year
N/A
$4.67
P/E Ratio
N/A
$95.25
Revenue Growth
N/A
5.41
52 Week Low
$9.10
$6.96
52 Week High
$40.43
$10.85

Technical Indicators

Market Signals
Indicator
MPLT
HLMN
Relative Strength Index (RSI) 39.90 38.48
Support Level $12.24 $7.02
Resistance Level $20.20 $7.73
Average True Range (ATR) 0.94 0.29
MACD 0.89 -0.12
Stochastic Oscillator 76.10 18.62

Price Performance

Historical Comparison
MPLT
HLMN

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

About HLMN Hillman Solutions Corp.

Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the company are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the U.S, Canada and Mexico.

Share on Social Networks: